RAPT Therapeutics Inc
RAPT10.760USD
+0.270+2.57%
終値 08/04, 16:00（ET）15分遅れの株価
10.760USD+10.760時間外取引 (ET)
177.55M時価総額
損失額直近12ヶ月PER
四半期
四半期+年間
四半期
年間
YOY
空白行を非表示にする
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2020Q2
FY2020Q1
FY2019Q4
FY2019Q3
FY2019Q2
FY2019Q1
FY2018Q4
FY2018Q3
FY2018Q2
FY2018Q1
総売上高
----
----
----
----
----
--0.00
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
1.96%886.00K
-47.55%641.00K
-41.94%756.00K
-36.78%966.00K
-31.95%869.00K
30.70%1.22M
--1.30M
--1.53M
--1.28M
--935.00K
----
----
----
----
----
----
----
----
収益
----
----
----
----
----
--0.00
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
1.96%886.00K
-47.55%641.00K
-41.94%756.00K
-36.78%966.00K
-31.95%869.00K
30.70%1.22M
--1.30M
--1.53M
--1.28M
--935.00K
----
----
----
----
----
----
----
----
営業費用
-40.76%19.27M
63.97%54.47M
-41.66%19.79M
3.41%29.33M
3.03%32.52M
35.96%33.22M
56.47%33.92M
43.29%28.36M
47.36%31.56M
30.02%24.43M
11.17%21.68M
16.78%19.80M
20.44%21.42M
30.60%18.79M
21.04%19.50M
22.93%16.95M
27.28%17.78M
12.27%14.39M
56.17%16.11M
25.81%13.79M
46.40%13.97M
32.51%12.81M
-2.18%10.31M
30.96%10.96M
14.12%9.54M
--9.67M
--10.54M
--8.37M
--8.36M
研究 & 開発費
-51.41%12.04M
73.58%46.46M
-50.63%13.34M
4.61%22.64M
-3.10%24.78M
37.58%26.76M
62.79%27.02M
50.72%21.64M
53.41%25.57M
36.05%19.45M
5.56%16.60M
8.86%14.36M
21.05%16.67M
31.14%14.30M
21.79%15.72M
20.06%13.19M
28.91%13.77M
7.01%10.90M
50.45%12.91M
32.89%10.99M
35.74%10.68M
21.60%10.19M
-6.52%8.58M
19.81%8.27M
7.72%7.87M
--8.38M
--9.18M
--6.90M
--7.31M
減価償却費、減耗費および償却費
-4.46%300.00K
-7.12%300.00K
-7.69%300.00K
1.67%305.00K
4.67%314.00K
28.17%323.00K
8.33%325.00K
9.49%300.00K
14.94%300.00K
-64.00%252.00K
31.00%300.00K
7.03%274.00K
-6.79%261.00K
164.15%700.00K
-23.67%229.00K
-36.00%256.00K
40.00%280.00K
-16.93%265.00K
-12.28%300.00K
-20.00%400.00K
-39.58%200.00K
6.33%319.00K
10.68%342.00K
55.28%500.00K
6.09%331.00K
--300.00K
--309.00K
--322.00K
--312.00K
営業利益
40.76%-19.27M
-63.97%-54.47M
41.66%-19.79M
-3.41%-29.33M
-3.03%-32.52M
-35.96%-33.22M
-56.47%-33.92M
-50.00%-28.36M
-51.91%-31.56M
-35.47%-24.43M
-16.97%-21.68M
-17.59%-18.91M
-25.46%-20.78M
-37.82%-18.03M
-27.10%-18.53M
-28.53%-16.08M
-27.03%-16.56M
-2.11%-13.09M
-41.36%-14.58M
-14.16%-12.51M
-36.60%-13.04M
-32.51%-12.81M
2.18%-10.31M
-30.96%-10.96M
-14.12%-9.54M
---9.67M
---10.54M
---8.37M
---8.36M
営業外受取（支払）利息純額
その他営業外収益（費用）
5.16%2.10M
-48.06%1.22M
-46.78%1.36M
-45.95%1.67M
-12.83%2.00M
58.18%2.34M
475.17%2.55M
1221.45%3.08M
641.42%2.29M
1309.52%1.48M
475.42%443.00K
-848.28%-275.00K
557.45%309.00K
-80.87%105.00K
-149.79%-118.00K
-107.42%-29.00K
-65.19%47.00K
111.97%549.00K
-31.10%237.00K
17.42%391.00K
-62.08%135.00K
7.47%259.00K
31.80%344.00K
103.05%333.00K
169.70%356.00K
--241.00K
--261.00K
--164.00K
--132.00K
税引前利益
43.76%-17.16M
-72.46%-53.25M
41.25%-18.43M
-9.43%-27.66M
-4.27%-30.52M
-34.53%-30.88M
-47.73%-31.37M
-31.78%-25.28M
-43.01%-29.27M
-28.01%-22.95M
-13.85%-21.23M
-19.08%-19.18M
-23.94%-20.47M
-43.02%-17.93M
-30.03%-18.65M
-32.92%-16.11M
-28.00%-16.51M
0.16%-12.54M
-43.86%-14.34M
-14.06%-12.12M
-40.42%-12.90M
-33.15%-12.56M
3.04%-9.97M
-29.52%-10.63M
-11.63%-9.19M
---9.43M
---10.28M
---8.20M
---8.23M
法人税等
----
----
----
----
----
----
----
----
----
----
----
----
----
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-69.85%199.00K
--287.00K
--267.00K
--237.00K
--660.00K
----
----
----
----
----
----
----
税引後利益
43.76%-17.16M
-72.46%-53.25M
41.25%-18.43M
-9.43%-27.66M
-4.27%-30.52M
-34.53%-30.88M
-47.73%-31.37M
-31.78%-25.28M
-43.01%-29.27M
-28.01%-22.95M
-13.85%-21.23M
-19.08%-19.18M
-23.94%-20.47M
-40.79%-17.93M
-27.48%-18.65M
-30.06%-16.11M
-25.69%-16.51M
3.64%-12.73M
-46.74%-14.63M
-16.57%-12.39M
-43.00%-13.14M
-40.15%-13.22M
3.04%-9.97M
-29.52%-10.63M
-11.63%-9.19M
---9.43M
---10.28M
---8.20M
---8.23M
継続事業による純利益
43.76%-17.16M
-72.46%-53.25M
41.25%-18.43M
-9.43%-27.66M
-4.27%-30.52M
-34.53%-30.88M
-47.73%-31.37M
-31.78%-25.28M
-43.01%-29.27M
-28.01%-22.95M
-13.85%-21.23M
-19.08%-19.18M
-23.94%-20.47M
-40.79%-17.93M
-27.48%-18.65M
-30.06%-16.11M
-25.69%-16.51M
3.64%-12.73M
-46.74%-14.63M
-16.57%-12.39M
-43.00%-13.14M
-40.15%-13.22M
3.04%-9.97M
-29.52%-10.63M
-11.63%-9.19M
---9.43M
---10.28M
---8.20M
---8.23M
親会社株主に帰属する当期純利益
43.76%-17.16M
-72.46%-53.25M
41.25%-18.43M
-9.43%-27.66M
-4.27%-30.52M
-34.53%-30.88M
-47.73%-31.37M
-31.78%-25.28M
-43.01%-29.27M
-28.01%-22.95M
-13.85%-21.23M
-19.08%-19.18M
-23.94%-20.47M
-40.79%-17.93M
-27.48%-18.65M
-30.06%-16.11M
-25.69%-16.51M
3.64%-12.73M
-46.74%-14.63M
-16.57%-12.39M
-43.00%-13.14M
-40.15%-13.22M
3.04%-9.97M
-29.52%-10.63M
-11.63%-9.19M
---9.43M
---10.28M
---8.20M
---8.23M
普通株主に帰属する純利益
43.76%-17.16M
-72.46%-53.25M
41.25%-18.43M
-9.43%-27.66M
-4.27%-30.52M
-34.53%-30.88M
-47.73%-31.37M
-31.78%-25.28M
-43.01%-29.27M
-28.01%-22.95M
-13.85%-21.23M
-19.08%-19.18M
-23.94%-20.47M
-40.79%-17.93M
-27.48%-18.65M
-30.06%-16.11M
-25.69%-16.51M
3.64%-12.73M
-46.74%-14.63M
-16.57%-12.39M
-43.00%-13.14M
-40.15%-13.22M
3.04%-9.97M
-29.52%-10.63M
-11.63%-9.19M
---9.43M
---10.28M
---8.20M
---8.23M
基本的1株当たり利益
89.91%-0.08
-41.92%-1.14
42.07%-0.47
-7.91%-0.71
-3.34%-0.79
-25.18%-0.80
-29.73%-0.82
-7.06%-0.66
-10.48%-0.76
-5.99%-0.64
0.32%-0.63
2.14%-0.62
-4.13%-0.69
-16.96%-0.61
-5.68%-0.63
-23.68%-0.63
-17.70%-0.66
10.77%-0.52
-36.54%-0.60
-8.98%-0.51
-39.83%-0.56
-40.15%-0.58
3.04%-0.44
-29.52%-0.47
-11.63%-0.40
---0.41
---0.45
---0.36
---0.36
希薄化後1株当たり利益
89.91%-0.08
-41.92%-1.14
42.07%-0.47
-7.91%-0.71
-3.34%-0.79
-25.18%-0.80
-29.73%-0.82
-7.06%-0.66
-10.48%-0.76
-5.99%-0.64
0.32%-0.63
2.14%-0.62
-4.13%-0.69
-16.96%-0.61
-5.68%-0.63
-23.68%-0.63
-17.70%-0.66
10.77%-0.52
-36.54%-0.60
-8.98%-0.51
-39.83%-0.56
-40.15%-0.58
3.04%-0.44
-29.52%-0.47
-11.63%-0.40
---0.41
---0.45
---0.36
---0.36
1株当たり配当金
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
通貨単位
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
監査意見
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
